Cell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development. - Wikidata - awgldk - TriplyDB

Cell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development.

Cell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development.

http://www.wikidata.org/entity/Q38088759

about

Sesquiterpene lactones isolated from indigenous Middle Eastern plants inhibit tumor promoter-induced transformation of JB6 cells.Molecular insights into the anti-cancer properties of traditional Tibetan medicine Yukyung Karne Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis.Crystal structure determination of new antimitotic agent bis(p-fluorobenzyl)trisulfide.Induction of apoptosis in human glioma cell lines of various grades through the ROS-mediated mitochondrial pathway and caspase activation by Rhaponticum carthamoides transformed root extract.γH2AX formation kinetics in PBMCs of rabbits exposed to acute and fractionated radiation and attenuation of focus frequency through preadministration of a combination of podophyllotoxin and rutin hydrate.Synergistic anticancer activities of the plant-derived sesquiterpene lactones salograviolide A and iso-seco-tanapartholide.Antioxidant and cytotoxic activities of Dendrobium moniliforme extracts and the detection of related compounds by GC-MS.

P2860

Q34331288-67FF2968-5F1A-478A-95F0-598A19B8901E Q34340137-CC5C8772-70C8-41FD-B301-365259B746EF Q38585273-FF19BC91-E8EE-480C-95A5-1FB6CC2676B9 Q42374274-E2C1B1D7-0A2F-47A4-A524-3ABCA7C72F9C Q46241524-93054C99-038D-4085-A467-1B90B87B41E7 Q51685160-E7099336-AE1F-4F6E-AB33-A647F334E5E5 Q52629734-D260D661-DA99-4C4F-887E-5B6E63FB7E8D Q55052214-33CA72FF-13B7-4449-9B63-BAB33CDD9F3D

P2860

Cell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development.

http://www.wikidata.org/entity/Q38088759

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Cell cycle modulatory and apop ...... n clinical use or development.

@en

type

label

Cell cycle modulatory and apop ...... n clinical use or development.

@en

prefLabel

Cell cycle modulatory and apop ...... n clinical use or development.

@en

P1433

Q38088759-8CBDC8EB-71E7-42C3-8391-79D2EDC18CEB

P1476

Q38088759-A11CBA8F-98D5-47B0-93E4-08B1CF504062

P2093

Q38088759-2845569D-91FF-4388-BB6F-D49375A815FD

Q38088759-3DC03ADA-A033-491F-B5D4-2EB081892101

Q38088759-44DD1689-7E09-4745-98EC-85EDE7733BC9

P2860

Q38088759-01308C30-8885-4E99-955A-9672FC10157C

Q38088759-046C9EA7-6933-44E3-807B-FBB052DCF867

Q38088759-067F204A-DD3E-4CA5-857C-B805400ECF15

Q38088759-074AF554-7E0D-43A4-ABF9-759F416BA109

Q38088759-07F8CA1B-7CFC-468D-BF22-C7F8185D7DCB

Q38088759-0D3E7598-337C-4FB4-A454-FA4A33241BD1

Q38088759-0DA12852-C7B5-4FB9-AE9F-9CD293E5F2A7

Q38088759-102CCD13-C2E1-4A0A-9B5D-E3F35E2CA2BE

Q38088759-10E087F0-941D-4DE8-905E-BC947CF891F7

Q38088759-11AC1931-F6D7-448F-8B14-09644366530C

P304

Q38088759-3DA40F7C-8AE8-459A-B365-331900950053

P31

Q38088759-12AFAD7A-C288-4D34-86B8-E59D8C5518F4

P356

Q38088759-FDA5F6E9-BB2B-4E44-8B58-48663A2835B5

P407

Q38088759-E89DC594-1E0C-4E8D-B4DF-2B7273348944

P433

Q38088759-EDBB804F-6F3C-4CDC-B04A-E594B3AD957F

P478

Q38088759-63C7F3A2-0DC5-41B0-8BA4-6DA91CFB3B30

P50

Q38088759-EA358DCB-B2D1-4781-84CB-853B1DFAEF7E

P577

Q38088759-4796EC8E-E0A0-4CB4-91B2-47D5644E56E6

P5875

Q38088759-4E030336-2008-4C02-9038-D0F2E946FE2D

P698

Q38088759-14795A6F-46BD-4BEE-99D0-25C37B7CE104

P921

Q38088759-7FE95394-C118-4616-9B77-DD0AEBD3894A

P356

17460441.2.3.361

P1433

Expert Opinion on Drug Discovery

P1476

Cell cycle modulatory and apop ...... n clinical use or development.

@en

P2093

Hala Gali-Muhtasib

http://www.w3.org/2001/XMLSchema#string

Nadine Darwiche

http://www.w3.org/2001/XMLSchema#string

Sara El-Banna

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence that low doses of Taxol enhance the functional transactivatory properties of p53 on p21 waf promoter in MCF-7 breast cancer cells

Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics

Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma

Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine

The evolving role of natural products in drug discovery

Podophyllotoxin derivatives: current synthetic approaches for new anticancer agents

Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1

Plants as a source of anti-cancer agents

Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo

Taxol induces caspase-10-dependent apoptosis

P304

361-379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17460441.2.3.361

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Hala Gali-Muhtasib

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236040970

http://www.w3.org/2001/XMLSchema#string

P698

23484647

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process